Value
7.7/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 8.5 |
| P/S | 8.0 |
| EV/EBITDA | 8.0 |
| Fwd P/E | 9.2 |
| PEG | 4.2 |
| Analyst target | 9.0 |
- ▸Forward P/E: 10.9x
- ▸PEG: 2.35
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
SBC Medical is a high-quality, fast-growing business with 27% margins and 193% cash conversion, but the stock sits at its 52-week high with only 7.0% upside to the analyst target and extreme volatility.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Quality is high at 9.2/10, with 27% margins, 193% free cash flow to net income, a Piotroski F-Score of 9/9 and a Rule of 40 of 88. Quality breakdown | Margins should stay above 20% and free cash flow conversion above 100% over the next 12 months. | ↑Improving |
| CounterCash conversion of 193% and margins this high are unusual for a consulting-services firm and may reflect timing of prepayments that will reverse. | ||
Growth is strong at 35% YoY, ranking the company an industry growth leader among peers. Growth breakdown | Revenue growth should stay above 20% YoY through the next 4 quarters. | ↑Improving |
| CounterA PEG of 2.06 suggests the market already pays a full price for this growth, leaving little room if growth slows. | ||
The stock is within 0.4% of its 52-week high with only 7.0% upside to the analyst target against 15.0% downside, a reward-to-risk of 0.46. Bear case | Analyst targets should be raised above $9, or price should consolidate, to restore a positive reward-to-risk. | ↓Deteriorating |
| CounterMomentum is strong at 8.7/10 with rising volume, so a stock at highs can keep rising and the target may simply lag. | ||
Momentum is overbought (RSI 75) after an extreme 18.9% gap up and a 6.3x volume surge, with implied volatility at 171%. Momentum breakdown | Price should consolidate without losing more than 15% from the current $7.35. | ↑Improving |
| CounterOverbought readings after a volume surge on an up move often precede a pullback, and a put/call ratio of 9.00 shows heavy hedging demand. | ||
The latest quarter beat with EPS of 0.15 versus 0.12 expected, and earnings have met or beaten estimates in 3 of the last 4 quarters. Earnings | EPS should stay at or above 0.12 per quarter. | ↑Improving |
| CounterOne quarter was a 14.89% miss and another only in line, so the beat record is not uniformly strong. | ||
CounterCash conversion of 193% and margins this high are unusual for a consulting-services firm and may reflect timing of prepayments that will reverse.
CounterA PEG of 2.06 suggests the market already pays a full price for this growth, leaving little room if growth slows.
CounterMomentum is strong at 8.7/10 with rising volume, so a stock at highs can keep rising and the target may simply lag.
CounterOverbought readings after a volume surge on an up move often precede a pullback, and a put/call ratio of 9.00 shows heavy hedging demand.
CounterOne quarter was a 14.89% miss and another only in line, so the beat record is not uniformly strong.
| Component | Sub-score |
|---|---|
| P/E | 8.5 |
| P/S | 8.0 |
| EV/EBITDA | 8.0 |
| Fwd P/E | 9.2 |
| PEG | 4.2 |
| Analyst target | 9.0 |
| Component | Sub-score |
|---|---|
| ROE | 6.4 |
| ROA | 8.5 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 9.3 |
| FCF quality | 10.0 |
| Moat | 8.4 |
| Rule of 40 | 9.5 |
| Piotroski F | 10.0 |
| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 6.5 |
| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 7.4 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 5.5 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 5.8 |
| Analyst rating | 7.1 |
| Price target | 9.9 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
| Component | Sub-score |
|---|---|
| value rank | 5.5 |
| quality rank | 6.3 |
| growth rank | 8.9 |
| Component | Sub-score |
|---|---|
| bollinger | 4.7 |
| support resistance | 7.0 |
| 52w position | 5.2 |
| gap | 6.0 |
| Component | Sub-score |
|---|---|
| short interest | 7.8 |
| days to cover | 6.1 |
| volatility | 0.0 |
| put call | 2.2 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 9.9 |
| debt equity | 9.4 |
| news risk | 6.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 8.0 |
Value play: 51% MoS with quality 9.2. (held at prior verdict — engine reading is near the momentum/RSI threshold; will commit on clearer signal).
L4:PATH_A_VALUE_MOS33|STABILIZER:PROMOTE_DEAD_ZONE|ENTRY_STICKY:WITHIN_BANDnone
SetupBreakout — Golden cross, above all MAs, RSI 53, MACD bullish
EdgeInst Constrain — Small cap ($0.6B) below institutional reach
SuitabilityAggressive — MCap $0.6B<$5B
The STRONG_BUY_WAIT verdict reflects clean gate clearance against Quality at 9.2 and asymmetric R:R of 3.45.
The strongest dimensions are Quality at 9.2, Growth at 8.2, and Value at 7.7; the weakest are Risk (lower is worse) at 4.9, Technical at 5.7, and Momentum at 5.7. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 3.45 and an engine sizing output of STARTER.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifFree cash flow to net income falls below 100% from the current 193%.
Trip ifRevenue growth falls below 15% YoY from the current 35%.
Trip ifPrice falls more than 15% below the current $7.35.
Trip ifImplied volatility stays above 150% for 2 consecutive quarters while the price drops below $6.49.
Trip ifQuarterly EPS falls below 0.10 from the latest 0.15.